CPT® Code 87531

The CPT® Code 87531 refers to a laboratory test designed for the detection of the infectious agent known as human herpes virus-6 (HHV-6) through the analysis of nucleic acids, specifically DNA or RNA. HHV-6 is a virus that can lead to various clinical manifestations, particularly in children and immunocompromised individuals. The two variants of this virus, HHV-6A and HHV-6B, are associated with different illnesses; HHV-6A is primarily linked to roseola infantum, a common childhood illness characterized by fever and rash, while HHV-6B can cause a mononucleosis-like syndrome in those with weakened immune systems. The test utilizes a direct probe technique to identify the unique nucleic acid sequence of HHV-6, which is referred to as the target sequence. This sequence is detected in biological samples such as blood or cerebrospinal fluid (CSF). The process involves treating the sample to release nucleic acids from the virus, if present, and then applying a labeled probe that specifically binds to the target sequence, forming a stable hybrid. The probes used in this test are often labeled with fluorescent or chemiluminescent markers, enhancing the detection process. In the context of HHV-6 detection, ribosomal RNA is frequently targeted due to its abundance in microorganisms, which allows for more effective identification compared to genomic DNA. This method is distinct from the amplified probe technique, which is covered under CPT® Code 87532, where the sensitivity of the assay is significantly improved by exponentially amplifying the target nucleic acid sequence. The most prevalent amplification methods include polymerase chain reaction (PCR) and reverse transcriptase polymerase chain reaction (RT-PCR). Furthermore, CPT® Code 87533 pertains to nucleic acid detection with quantification, providing insights into the quantity of microorganisms present in the sample through quantitative or real-time PCR techniques. This comprehensive approach to nucleic acid detection is crucial for accurate diagnosis and management of infections caused by HHV-6.